Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma by Räsänen, Kati et al.
Differences in the Nemosis Response of Normal and
Cancer-Associated Fibroblasts from Patients with Oral
Squamous Cell Carcinoma
Kati Ra¨sa¨nen1*, Ismo Virtanen2, Pertteli Salmenpera¨1, Reidar Grenman3, Antti Vaheri1
1Haartman Institute, University of Helsinki, Helsinki, Finland, 2 Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland, 3Department of
Otorhinolaryngology - Head and Neck Surgery, Turku University Central Hospital, Turku, Finland
Abstract
Background: Tumor-stroma reaction is associated with activation of fibroblasts. Nemosis is a novel type of fibroblast
activation. It leads to an increased production of growth factors and proinflammatory and proteolytic proteins, while at the
same time cytoskeletal proteins are degraded. Here we used paired normal skin fibroblasts and cancer-associated
fibroblasts (CAF) and primary and recurrent oral squamous cell carcinoma (SCC) cells to study the nemosis response.
Principal Findings: Fibroblast nemosis was analyzed by protein and gene expression and the paracrine regulation with
colony formation assay. One of the normal fibroblast strains, FB-43, upregulated COX-2 in nemosis, but FB-74 cells did not.
In contrast, CAF-74 spheroids expressed COX-2 but CAF-43 cells did not. Alpha-SMA protein was expressed in both CAF
strains and in FB-74 cells, but not in FB-43 fibroblasts. Its mRNA levels were downregulated in nemosis, but the CAFs started
to regain the expression. FSP1 mRNA was downregulated in normal fibroblasts and CAF-74 cells, but not in CAF-43
fibroblasts. Serine protease FAP was upregulated in all fibroblasts, more so in nemotic CAFs. VEGF, HGF/SF and FGF7 mRNA
levels were upregulated to variable degree in nemosis. CAFs increased the colony formation of primary tumor cell lines UT-
SCC-43A and UT-SCC-74A, but normal fibroblasts inhibited the anchorage-independent growth of recurrent UT-SCC-43B
and UT-SCC-74B cells.
Conclusions: Nemosis response, as observed by COX-2 and growth factor induction, and expression of CAF markers a-SMA,
FSP1 and FAP, varies between fibroblast populations. The expression of CAF markers differs between normal fibroblasts and
CAFs in nemosis. These results emphasize the heterogeneity of fibroblasts and the evolving tumor-promoting properties of
CAFs.
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Introduction
Tumor microenvironment plays a major role in cancer
progression and fibroblasts are known to be key components of
the tumor stroma. Recently it has been suggested that stromal
fibroblasts initially inhibit early stages of carcinogenesis and later
under the paracrine influence of the transformed epithelia become
activated leading to promotion of cancer growth. The dependence
of carcinomas on stromal fibroblasts decreases as the cancer
progresses, partly through a switch in epithelial cells from
paracrine to autocrine regulation [1,2]. Among the activated
fibroblasts are cancer-associated fibroblasts (CAF), that are
characterized by increased mitotic index, mutations in tumor
suppressor genes such as p53 and by increased secretion of growth
factors, chemokines and components of extracellular matrix
(ECM) [2,3], changes which all are involved in invasion and
tumor growth [4].Widely used CAF markers include a-smooth
muscle actin (a-SMA), fibroblast specific protein 1 (FSP1, also
known as S100A4) and fibroblast activation protein (FAP, also
known as seprase) [5]. a-SMA, a component of the cytoskeleton, is
the most often used marker for activated fibroblasts. It becomes
incorporated into stress fibers thereby augmenting the contractile
activity of the fibroblasts [6]. FSP1 belongs to the S100 super-
family of calcium-binding proteins. It promotes tumor growth by
regulating cell cycle progression and cytoskeletal integrity [7]. FAP
is a serine protease that is not expressed in normal adult tissues,
but its expression is induced in activated fibroblasts responding to
wound healing and tumor-stroma reaction [8]. However, it is well
established that fibroblasts are heterogeneous [9,10] and that
CAFs differently express these markers [11,12].
Nemosis, a phenomenon of fibroblast activation (for review see
Vaheri et al. 2009 [13]), has previously been studied using normal
dermal fibroblasts [14–19]. Formation of a fibroblast spheroid causes
myriad of genes to be differentially expressed in these activated
fibroblasts. Two distinct patterns can be found in the expression: i)
expression of growth factors and proteolytic and proinflammatory
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proteins increases and ii) expression of cytoskeletal components
decreases. Based on previously published results, cyclooxygenase-2
(COX-2), that is known to be associated with inflammation and early
stages of carcinogenesis, and hepatocyte growth factor / scatter
factor (HGF/SF), which has been shown to promote tumor cell
invasiveness, have been considered hallmark proteins of nemosis.
Spontaneous clustering of fibroblasts into spheroids can also be
induced by tumor cell conditioned medium [14,15]. We have
previously shown that culturing fibroblast spheroids under the
influence of benign HaCaT keratinocytes inhibits nemosis, as seen
by suppressed expression of COX-2, whereas malignant HaCaT
cells have a nemosis-promoting effect on normal fibroblasts,
manifested as enhanced upregulation on COX-2, HGF/SF and
VEGF (vascular endothelial growth factor) [17].
Head and neck squamous cell carcinoma (HNSCC) is the sixth
most common malignancy worldwide and the overall patient
survival is poor. This is mainly due to high rates of cancer
recurrence and local invasion, partly caused by p53 gene
mutations, which can be found in more than 70% of HNSCCs
[20,21]. Surgery and radiotherapy are the most commonly used
lines of treatment and currently the only approved molecular
targeted therapy for head and neck cancer is cetuximab (Erbitux;
ImClone Systems Inc., New York, NY), a monoclonal antibody
inhibitor of epidermal growth factor receptor (EGFR). However,
not all HNSCC patients benefit from EGFR-targeted therapies,
since overexpression, but not mutation seems to determine the
treatment response. Phase 3 trials for HNSCC are currently
underway for targeting VEGF (Bevacizumab, monoclonal anti-
body inhibitor) and for p53 (INGN 201, gene therapy) [22,23].
Another potential target is COX-2 that has been found to be
elevated in oral squamous cell carcinoma (OSCC) and has been
shown to decrease tumor radiosensitivity [24]. Studies using
matched patient cell strains have showed that there is a correlation
in radiosensitivities between OSCC cells, dermal fibroblasts and
cancer-associated fibroblasts collected from the same individual
and that these individual differences in the radiosensitivity might
predict the outcome of radiotherapy [25,26].
Based on the previous results that under the influence of
malignant cells normal nemotic fibroblasts start to resemble CAFs,
the objective of this work was to study the nemosis response of
autologous skin and cancer-associated fibroblasts, to compare the
expression of CAF markers between these fibroblasts strains and
their fate in nemosis and to investigate how these different
fibroblast populations influence the patient-matched oral SCC
cells. Our study shows that both normal and cancer-associated
fibroblasts show variation between individuals, seen as varying
basal CAF expression levels and different growth factor responses
in nemosis, and have a differential impact on the SCC cells. The
behaviour of the studied CAF markers in nemosis followed the
general nemosis response: cytoskeletal a-SMA and FSP1 were
downregulated and proteolytic FAP was upregulated. The only
exception was one of the CAF strains that upregulated FSP1 in
nemosis. Major systematic differences between normal and
cancer-associated fibroblasts were the decreased basal levels of
growth factors in CAFs and the capability of nemotic CAFs to start
to regain the a-SMA expression and the increased FAP expression
in nemosis compared to their normal counterparts.
Results
Different fibroblast populations show differences in
response to nemosis
First we wanted to investigate the expression of the previously
used nemosis marker COX-2 in the four fibroblast populations.
There was no basal expression of COX-2 in any of the fibroblast
strains, and it was not induced in monolayer culture. However,
when cultured as spheroids the normal fibroblasts FB-43 started to
express COX-2 after 48 hours (Figure 1A), but this was not seen in
the other normal fibroblasts strain FB-74 (Figure 1C). Opposite
results were seen with the cancer-associated fibroblasts, where no
COX-2 was expressed in the CAF-43 fibroblast spheroids
(Figure 1B) but the CAF-74 cells started to express COX-2 after
24 hours (Figure 1D). These results differ from previously
published and indicate that COX-2 should not be solely used to
measure nemosis response.
We also looked at the protein levels of vimentin and a-SMA in
these cells. All four fibroblast populations expressed vimentin in
equal amounts, as expected, since fibroblasts in vitro are considered
to be in a state resembling wound healing. Both CAF strains
expressed a-SMA, CAF-74 slightly more than CAF-43. Interest-
ingly, also the normal FB-74 cells expressed a-SMA, but no
protein expression was detected in the other normal fibroblast cell
strain FB-43. Time-dependent downregulation of a-SMA was seen
in spheroids but not in the monolayer cultures, caused by the
degradation of cytoskeleton in these fibroblasts going through
nemosis. This is in line with previous results by Bizik et al. [14],
where decreasing actin levels were used as a marker of spheroid
degradation. GAPDH was used as a loading control.
Figure 1E is an immunoblot of the four UT-SCC carcinoma cell
lines. All of them expressed COX-2, but interestingly only UT-
SCC 74A and 74B had an induced p53 protein level, suggesting a
p53 mutation. We could not detect p53 in any of the fibroblast
populations, a notion that concurs with the report by Qiu et al.
[27] in which they could not detect somatic genetic alterations in
CAFs.
Different expression of CAF markers in fibroblast strains
Since the protein levels of a-SMA varied between different
fibroblast populations, we decided to investigate also the
expression of other widely used CAF markers FSP1 and FAP.
Gene expression pattern of these three genes in the fibroblasts
grown as spheroids for 0, 24, 48 and 72 hours was analyzed using
quantitative real-time PCR. Q-PCR was chosen as the method
over immunoblotting because of its higher sensitivity. GAPDH
was used as a reference gene that the expression of target genes
was normalized to, after which relative fold expression ratios were
calculated. The basal expression level of a-SMA, FSP1 and FAP
was significantly lower (P,0.01) in CAF-43 cells than in normal
FB-43 fibroblasts (Figure 2A). However, as seen in Figure 2B, this
was not the case with CAF-74 fibroblasts, where compared to FB-
74 cells a-SMA expression ratio was equal, FSP1 1.4-fold higher
and FAP expression ratio surprisingly 10-fold higher (P,0.01).
Nemosis response of the CAF markers between these fibroblast
populations showed also variation. The a-SMA level was drastically
downregulated in spheroids, reflecting the protein levels and
indicating the decomposition of cytoskeleton in these spheroids.
This was also true for FB-43 cells, for which we could not detect
protein expression. Differing from the normal fibroblasts, the CAFs
started to regain the a-SMA expression at 72 hours; when
compared to normal fibroblasts the increase was statistically
significant (P,0.05) (Figure 2C). FSP1 mRNA decreased, as
expected, in both normal fibroblast cell strains and in CAF-74
cells, but surprisingly increased in CAF-43 spheroids (Figure 2D).
The third CAF marker FAP was induced in nemosis in all fibroblast
populations, following the general nemosis fingerprint. This
induction was higher in CAF spheroids than in normal fibroblast
spheroids (P,0.05 in CAF-43 vs. FB-43, not statistically significant
in 73 cells due to high variation between samples) (Figure 2E).
Nemosis Response in CAFs
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Differential expression of growth factors in normal and
cancer-associated fibroblasts
The other hallmark of nemosis is the increased production of
several growth factors, including VEGF, HGF/SF and FGF7
(KGF). Therefore we used Q-PCR to study the expression levels of
these genes in the four fibroblast populations. Both CAF strains
had lower basal expression levels of VEGF, HGF/SF (P,0.05)
and FGF7 (P,0.01) mRNA compared to the paired normal
fibroblasts (Figure 3A and 3B). When grown as spheroids all four
fibroblast populations showed upregulated VEGF, HGF/SF and
FGF7 mRNA expression. VEGF induction was highest in CAF-74
cells (over 15-fold) (Figure 3C), whereas highest HGF/SF
induction was seen in CAF-43 cells (over 30-fold) (Figure 3D).
FGF7 levels were regulated slightly differently; over 6-fold
induction was observed in FB-43 cells, other cells had an average
of 5-fold induction, and interestingly in CAF-74 cells at the
72 hour time point this induction had come down to 2.5-fold
(Figure 3E).
Paracrine regulation between fibroblasts and SCC cells
Anchorage-independent growth of UT-SCC carcinoma cell
lines was tested using the soft-agarose assay. During the three-week
observation period all four carcinoma cell lines formed colonies,
but clear difference between primary and recurrent tumor cell
lines was seen (Figure 4). When cultured alone, both recurrent
tumor cell lines UT-SCC-43B and UT-SCC-74B formed twice the
amount of colonies compared to primary tumor cell lines UT-
SCC-43A and UT-SCC-74A; the difference was statistically
significant in both cases (P,0.05). The underlying monolayer of
normal fibroblasts FB-43 and FB-74 increased slightly the number
of 43A and 74A carcinoma cell colonies, respectively. Increase in
colony numbers was further augmented when 43A and 74A SCC
Figure 1. Nemosis response in different fibroblast populations. Fibroblasts were grown as spheroids or monolayer for the time indicated. (A)
FB-43 spheroids started to produce COX-2 after 48 hours and no a-SMA was produced, whereas CAF-43 cells (B) did not induce COX-2 but expressed
a-SMA. Both FB-74 (C) and CAF-74 (D) produced a-SMA, but COX-2 was only induced in CAF-74 spheroids. All fibroblasts types expressed equal
amounts of vimentin. (E) All UT-SCC cells expressed COX-2, but only 74A and 74B showed induced p53 levels.
doi:10.1371/journal.pone.0006879.g001
Nemosis Response in CAFs
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cells were grown under the influence of CAF-43 and CAF-74
(P,0.05), respectively. Interestingly, when culturing the more
invasive 43B and 74B SCC cells with FB-43 and FB-74 fibroblasts,
a decrease in colony number was seen; this effect was more
pronounced with 74B cells (P,0.05 in FB-74 compared to
control). CAF-43 and CAF-74 fibroblasts restored the number of
colonies to same level as control, but did not further enhance the
colony formation of recurrent SCC cells.
The UT-SCC colony formation results were in line between
cells obtained from the two individuals; however, there was
variation between individuals when observing closely the under-
lying monolayer fibroblast cultures. Spontaneous spheroid forma-
tion was seen in the underlying monolayer culture of FB-43 and
CAF-43 fibroblasts when co-cultured with both 43A and 43B SCC
cells (Figure 5A–D). FB-74 and CAF-74 did not spontaneously
form spheroids under any of the above conditions, but they did
grow faster when co-cultured with more malignant 74B cells
(Figure 5G–H). Figures 5I–J presents the spontaneous spheroid
formation of 43 fibroblasts with 43A and 43B SCC cells. With
both UT-SCC cell lines, CAF-43 cells formed significantly more
spheroids than FB-43 fibroblasts (P,0.05). The two different SCC
cell lines did not influence significantly the fibroblast spheroid
formation; although a slight increase was seen in CAF-43
spheroids with recurrent 43B SCC cells. None of the fibroblast
types (FB-43, CAF-43, FB-74 and CAF-74) formed colonies in soft
agarose.
To elucidate the reason for the different behavior of the fibroblast
strains on monolayer cultures, and particularly the slow growth rate
of CAF-74 cells, we performed senescence-associated beta-galacto-
sidase (SA-b-gal) staining. SA-b-gal activity is the most commonly
used marker for cellular senescence. Premature stress-induced
senescence is caused by oxidative stress, DNA damage and
oncogene activation [28]. As expected, CAF-74 cells showed strong
SA-b-gal staining. CAF-43 fibroblasts were as well positive, but
CAF-74 had significantly more (P,0.01) senescent cells (Figure 6).
Discussion
Primary carcinomas are considered to be unorganized organs
that are composed of various cell types, including cancer cells,
fibroblasts and other mesenchymal cells, and cells related to
immunity and vasculature. The tumor-stroma microenvironment
leads to fibroblast activation and paracrine signaling between
fibroblasts and cancer cells [29]. In nemosis, activated fibroblasts
start to produce proteins involved in inflammation, proteolysis and
cancer progression and at the same time downregulate the
expression of cytoskeletal proteins [14–19].
The objective of this work was to investigate the nemosis
response of patient-matched normal and cancer-associated
fibroblasts, and to study the expression pattern of CAF markers
and their behaviour in nemosis. Only one of the normal fibroblast
strains (FB-43) and one of the CAFs (FB-74) induced COX-2 in
nemosis. This is in contrast with previously published results,
where COX-2 induction has been considered a hallmark feature
of nemosis. However, in those studies fibroblasts have been from
neonatal origin and here we have used fibroblasts obtained from
Figure 2. CAF marker mRNA expression. Gene expression of CAF markers was studied using Q-PCR. (A) a-SMA, FSP1 and FAP expression ratios
were significantly lower (P,0.01) in CAF-43 cells compared to FB-43 cells, but equal or higher in CAF-74 fibroblasts. (B) When grown as spheroids all
fibroblasts downregulated a-SMA expression, but CAFs started to regain the expression at 72 h (P,0.05 in FB-43 vs. CAF-43 and in FB-74 vs. CAF-74)
(C) FSP1 was downregulated in normal fibroblasts and in CAF-74 cells, but not in CAF-43 cells, (D) and FAP was upregulated in all cell lines going
through nemosis, more so in CAFs (P,0.05 in 72 h CAF-43 when compared to 72 h FB-43 ). Columns: mean; error bars; SEM.
doi:10.1371/journal.pone.0006879.g002
Nemosis Response in CAFs
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adults. This conflicting result therefore indicates that COX-2
should not be solely used to measure nemosis response, but other
markers, such as the profile of secreted proteins, should be
investigated as well.
The other key feature of nemosis is the time-dependent
degradation of cytoskeleton. On protein level three of the
fibroblast strains expressed a-SMA, surprisingly also the normal
skin fibroblasts FB-74. The other normal fibroblast strain FB-43
did not express a-SMA at the protein level. However, when
measuring the mRNA levels with the more sensitive Q-PCR
method, all four fibroblast populations showed a-SMA expression
and this was downregulated in nemosis. The time-dependent
downregulation on both protein and mRNA level is in line with
previous results on nemosis, indicating the decomposition of the
cytoskeleton. Interestingly the CAFs started to regain the a-SMA
mRNA expression at 72 h, the difference was significant when
compared to their normal counterparts. In contrast to our results,
a study by Shannon et al. [30] showed that normal skin fibroblasts,
but not oral fibroblasts expressed a-SMA. However, more recent
results showed, in line with our results, that normal oral fibroblasts
express a-SMA and this expression increased when these cells
were cultured in conditioned medium obtained from OSCC cells
[31]. These contradicting results might come partly from the
method that was used to measure the a-SMA expression; in the
first one immunoblotting was used, in the second the method was
slightly more sensitive immunohistochemistry.
We investigated also the mRNA levels of two other CAF
markers, FSP1 and FAP. In nemosis FSP1 levels decreased in FB-
43, FB-74 and CAF-74 spheroids, but increased in CAF-43 cells.
The third investigated CAF marker FAP was upregulated in
nemosis, more in CAFs than in normal fibroblasts, the difference
was significant with the 43 fibroblast strains. With all three CAF
markers the nemosis response followed the pattern of decreased
expression of cytoskeletal genes (a-SMA and FSP1) and increase in
proteolytic gene expression (FAP). Clearly different response was
seen with CAF-43 cells where, instead of downregulation of FSP1,
the levels increased in nemosis.The heterogeneity of fibroblasts
becomes evident when looking at the basal levels of the CAF
marker expression; CAF-43 cells had lower levels of all three
markers, CAF-74 had less a-SMA, slightly more FSP1 and over
10-fold more FAP. These results also emphasize that a-SMA, the
most commonly used CAF / myofibroblast marker, should not be
used solely to define activated fibroblasts.
Another hallmark of nemosis is the induction of growth factors. It
has been shown that oral fibroblasts produce significantly more
FGF7 and HGF/SF when compared to skin fibroblasts [30]. These
two growth factors, together with VEGF, are known to be
important in wound repair and cancer progression [32,33]. The
basal expression of VEGF, HGF/SF and FGF7 mRNA was lower
in CAFs than in normal fibroblasts, and this is in contrast to
previous results [30]. However, the growth rate of these cells was
slower than that of their normal counterparts, which might reflect
their decreased production of growth factors. The SA-b-gal activity
of the CAFs supports this theory, indicating that these cells are
senescent. The need for these growth factors to be secreted by
fibroblasts could be reduced in the CAFs since the tumor cells
themselves, along with infiltrated macrophages and endothelial
cells, are capable to produce these factors. As expected, VEGF,
HGF/SF and FGF7 mRNAs were upregulated in fibroblast
nemosis, and the level of induction varied between fibroblast
populations. VEGF induction was highest in CAF-74 spheroids,
HGF/SF in CAF-43 spheroids and FGF7 in FB-43 spheroids.
Figure 3. Growth factor mRNA levels. Growth factor gene expression was studied using Q-PCR. (A and B) Both CAF cell lines had reduced
expression of HGF/SF (P,0.05) and FGF7 (P,0.01) and all three growth factors were upregulated to a varying degree in nemosis (C – VEGF, D – HGF/
SF and E – FGF7). Columns: mean; error bars; SEM.
doi:10.1371/journal.pone.0006879.g003
Nemosis Response in CAFs
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Based on these results it seems that the capability of normal and
cancer-associated fibroblasts to produce these growth factors in
nemosis is somewhat related to the extent they are needed in
cancer progression. The dependence of tumors on stromal
fibroblasts, and particularly on the growth factors they produce,
decreases in the course of tumor progression. Epithelial cells
require FGF7 to break the epithelial polarization. FGF7 is only
expressed by stromal cells and its receptor FGFR2IIb only by
epithelial cells, indicating the role FGF7 in the beginning of tumor
progression [34]. Of the studied fibroblast populations the FB-43
cells, which appear to be most normal of the studied strains (based
of induction of COX-2 and lack of a-SMA), had the highest FGF7
induction in nemosis. HGF/SF is required for the migration /
scattering of the epithelial cells from the initial break point.
Nemotic CAF-43 cells produced more HGF/SF than the other
three cell strains. Supporting this Kankuri et al. [15] have shown
that HGF/SF produced by fibroblast spheroids directly promotes
cancer cell invasion. Also another study has shown that oral
fibroblasts drive invasion of OSCC cells by increasing secretion of
HGF/SF [35]. VEGF is required later in the tumor progression
when the cancer cell mass extends the point where it can no longer
grow without oxygen supply. VEGF, secreted by fibroblasts,
induces angiogenesis by recruiting endothelial cells to form new
blood vessels [36]. CAF-74 cells, which are senescent, have by far
the highest level of VEGF in nemosis.
It has been well established that CAFs, but not normal
fibroblasts, are capable to promote tumor progression [37–39].
More recent results have shown that initially the normal fibroblasts
inhibit the growth of cancer cells [2], and our present results
concur with that notion. We show here that normal fibroblasts
Figure 4. Soft-agarose assay scores. UT-SCC colony formation was studied with soft-agarose assay. All UT-SCC cells formed colonies in soft
agarose, recurrent SCC (B and D) twice as many as primary SCC cells (A and C) (P,0.05). Normal fibroblasts increased the number of colonies of
primary carcinomas cells and this was further augmented with CAF cells (P,0.05) (A and C). Recurrent SCC cell colony formation was inhibit with
normal fibroblasts (P,0.05 in FB-74 compared to control) and restored to control level by CAFs (B and C). Columns: mean; error bars; SEM.
doi:10.1371/journal.pone.0006879.g004
Nemosis Response in CAFs
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Figure 5. Fibroblast growth in soft-agarose assay. Representative pictures of underlying fibroblast monolayer cultures. Spontaneous clustering
(arrows) is seen in FB-43 and CAF-43 cells under the influence of paired SCC cells 43A (A and B) and 43B (C and D). In contrast, FB-74 (E and G) and
CAF-74 (F and H) did not form spheroids. Scale bar 60 mm. The number of formed spheroids was calculated from the monolayer fibroblast cultures (I
and J). CAF-43 cells formed significantly more spheroids than FB-43 cells (P,0.05). Columns: mean; error bars; SEM.
doi:10.1371/journal.pone.0006879.g005
Nemosis Response in CAFs
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indeed inhibit the colony formation of recurrent SCC cells, but
curiously this was not seen with primary tumor cells. The CAFs
seem to be able to influence only the primary SCC cells and not
the recurrent cells. The CAFs produced lower levels of growth
factors, and it could be that for this reason they are capable to
influence the more responsive primary SCCs, but the less sensitive
recurrent cells do not respond to this lower amount of secreted
growth factors.
The observed spontaneous spheroid formation of FB-43 and
CAF-43 in monolayer cultures is in line with the results from
Kankuri et al. [15], where spontaneous clustering of fibroblasts, i.e.
nemosis, could be achieved by adding tumor cell-derived condi-
tioned medium to a fibroblast monolayer. However, we did not find
this with the fibroblast strains from the other SCC patient. This
might be partly due to the induction of tumor suppressor p53 in the
74A and 74B SCC cells. Nonetheless, the fibroblasts did grow faster
under the influence of 74B SCC cells; this was also true with the
CAF-74 cells that seem to be in a state of stress-induced senescence.
Further more, we did not see anchorage-independent growth of the
fibroblasts, conflicting with the results obtained with prostate- and
prostate carcinoma associated fibroblasts [40]. Possible explanations
for this are individual variations and the origin of the fibroblasts. It is
worth noting that in the soft-agarose experiments the SCC cells and
fibroblasts were not in direct contact but separated by a solid layer of
agarose, and the cultures were not replenished by fresh medium.
Therefore the paracrine signaling between these two cell types must
be mediated by soluble factors.
In conclusion, this study clearly demonstrates that fibroblasts
obtained from different individuals vary in gene expression and
behavior and that the expression of CAF markers differs between
normal fibroblasts and CAFs in nemosis. Both normal and cancer-
associated fibroblasts modulate tumor cells, normal fibroblasts by
inhibiting the growth of invasive SCC cells and CAFs by further
enhancing the growth of primary SCC cells. Nemosis, an in vitro
model of fibroblast activation, may have its in vivo counterpart in
cancer-associated fibroblasts and is a valuable tool in studying the
variations between fibroblasts obtained from different individuals.
Nemosis response, particularly of the CAF markers a-SMA and
FAP, could therefore be used as a prognostic marker to predict the
stromal reaction of tumors.
Materials and Methods
Cell strains and cell culture
All used cell strains had been previously established [25,26,41]
and were provided by Dr Reidar Grenman (Turku University
Central Hospital, Finland). In brief, UT-SCC-43A (43A) cells were
obtained from primary tumor of a 75-year old female with gingival
ulceration and metastasis. Histology (T4N1M0) was a well-
differentiated SCC. UT-SCC-43B (43B) cells were established from
the resected recurrent tumor. UT-SCC-74A (74A) cells were
obtained from a 31-year old male having SCC in lingual right
margin (T3N1M0). UT-SCC-74B (74B) cell line was established
from a metastasis found later in the neck. The patient-matched FB-
43 and FB-74 normal fibroblasts were obtained from the skin and
CAF-43 and CAF-74 fibroblasts were obtained from the stroma of
the respective oral SCC. The mesenchymal origin of fibroblast
strains was originally confirmed by positive staining for vimentin
and negative staining for cytokeratin using immunohistochemistry.
All cell populations were cultured at +37uC in 5% CO2
atmosphere in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen, Carlsbad, CA) and supplemented with 5% fetal calf
serum (FCS) (Invitrogen), 0.3 mg/ml glutamine, 100 mg/ml
streptomycin and 100 U/ml penicillin. Fibroblast spheroids were
formed as described previously [17]. In brief, 150-ml aliquots/well
of single cell suspensions (1.36105 cells/ml) were plated on
agarose-coated U-bottom 96-well plates (Costar, Cambridge,
MA). Monolayer cultures were plated at the same density either
on flat-bottomed 96-well plates (for immunoblotting) or on 6-cm
dishes (for Q-PCR) (Greiner Bio-One, Frickenhausen, Germany).
Cells were harvested at 24 h, 48 h and 72 h. As zero-hour time
point the single cell suspension at the time of seeding was used.
Fibroblasts were used till passage number 20 and UT-SCC cell
lines till passage number 55.
Immunoblotting
The samples were harvested in 26 sample buffer (125 mM Tris
(pH 6.8), 4% sodium dodecyl sulfate (SDS), 0.01% bromophenol
blue, 10% b-mercaptoethanol, 10% glycerol) and equal amounts
of protein from each sample were resolved by 10% SDS-PAGE.
Proteins were transferred to nitrocellulose membrane (Schleicher
& Schuell, Dassel, Germany) and blocked with 2.5% non-fat
powdered milk in TBS (20 mM Tris-HCl pH 7.5, 150 mM NaCl
and 0.1% Tween-20).
The following primary antibodies were used: rabbit polyclonal
anti-COX-2 (Labvision, Fremont, CA), rabbit polyclonal anti-
GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA), mouse
monoclonal anti-a-SMA (DakoCytomation, Glostrup, Denmark),
mouse monoclonal anti-vimentin (65EE3; [42]) and mouse
monoclonal anti-p53 (DO-1, Thermo Fisher Scientific, Cheshire,
UK ) and secondary antibodies: horseradish peroxidase coupled
Figure 6. Senescence-associated beta-galactosidase activity of
fibroblasts. Representative pictures of fibroblast monolayer cultures
stained for SA-b-gal activity. FB-43 (A) and FB-74 (C) show little or no
staining; CAFs are positive (B and D). Scale bar 200 mm. CAF-74 had
significantly more (P,0.01) SA-b-gal cells compared to CAF-43 (E).
Columns: mean; error bars; SEM.
doi:10.1371/journal.pone.0006879.g006
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anti-rabbit IgG (Santa Cruz) and anti-mouse IgG+IgM (Jackson
Immunoresearch, Cambridgeshire, UK). Immunoreactive pro-
teins were visualized using ECL detection (Pierce, Rockford, IL).
Real-time quantitative PCR
The samples for Q-PCR were harvested in RNAprotect Cell
Reagent and total RNA was extracted according to the
manufacturer’s instructions using RNeasy Plus Mini kit (Qiagen,
Hilden, Germany). Using the SuperScript VILO cDNA synthesis
kit (Invitrogen) 500 ng of RNA from each sample were reverse-
transcribed according to the manufacturer’s instructions. Real-
time quantitative PCR was done using DyNAmo Capillary SYBR
Green Quantitative PCR kit (Finnzymes, Espoo, Finland) with a
LightCycler Instrument (Roche Applied Science, Mannheim,
Germany). Primer sequences are listed in Table 1; primers were
purchased from Oligomer (Helsinki, Finland). Relative expression
of target gene mRNA referenced to GAPDH was calculated using
the REST-MSC software’s Pair-Wise Fixed Reallocation Ran-
domization Test [43,44].
Soft-agarose assay
The colony formation assay was based on method described by
Zheng et al. [45], with minor modifications. All assays were done
in duplicate in 6-well plates (Costar). The bottom layer consisted
0.6% of L.M.P agarose (Invitrogen) in 26DMEM supplemented
with 10% FBS and was let to solidify. Next, 2-ml aliquots
containing 0.3 ml 1.8 % agarose, 0.7 ml DMEM and 1 ml single
cell suspension were layered on top of pre-coated wells, giving the
final concentration of top agarose 0.3%. Depending on experi-
ment, single cell suspension contained either 2.56104 fibroblasts /
ml or 56104 SCC cells / ml. In order to determine the role of
paracrine signaling between fibroblasts and carcinoma cells the
assay was modified so that fibroblasts (2.56104 fibroblasts / ml)
were first plated in wells as a monolayer and incubated for
24 hours. Medium was aspirated and bottom agarose was laid on
top of semi-confluent cells and allowed to solidify, after which the
top agarose with or without SCC cells (56104 SCC cells / ml) was
overlaid. The plates were cultured at +37uC in 5%-CO2 incubator
for 3 weeks without further feeding. The formed colonies were
scored by calculating number of colonies in ten random views of
106 magnification in duplicate using an inverted microscope
(Olympus CKX41) and photographed (Olympus DP12).
SA-b-gal staining
Senescence-associated beta-galactosidase (SA-b2gal) activity
was stained as described by Dimri et al. [46]. In brief, monolayer
cultures of fibroblasts were fixed with 2% paraformaldehyde /
0.2% glutaraldehyde in PBS for 5 min, washed with PBS, and
incubated with staining buffer (1 mg/ml X-gal, 150 mM NaCl,
2 mM MgCl2, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 in 40 mM
phosphate buffer, pH 6) over night. Images of random views were
captured at 46 magnification and the blue cells, indicating
senescence, were calculated.
Statistical analyses
All experiments were done in duplicates and repeated three
times. The mean and SEM of all three experiments are shown.
GraphPad Prism software was used to calculate statistical
significance that was determined by unpaired Student’s t-test.
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